관상동맥 중재술을 시행받은 급성심근경색증 환자에서 고중성지방혈증과 복부 비만이 예후에 미치는 영향
The Prognostic Impact of Hypertriglyceridemia and Abdominal Obesity in Acute Myocardial Infarction Patients Underwent Percutaneous Coronary Intervention
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although there are still controversies about whether hypertriglyceridemia is an independent risk factor for coronary arterydisease, recent analysis reported hypertriglyceridemia and central obesity are independent risk factors for coronary artery disease. However, the prognostic impact of hypertriglyceridemia and central obesity in acute myocardial infarction (AMI) patientsunderwent percutaneous coronary intervention (PCI) are still remained unclear. In this issue, Han et al. investigated the prognosticimpact of hypertriglyceridemia and/or central obesity on baseline in AMI patients treated with PCI. In this editorial, we havereviewed the role of hypertriglyceridemia and central obesity on the prognosis after PCI in AMI patients. Althoughhypertriglyceridemia and central obesity on baseline in this study had no role on the prognosis following PCI in AMI patients, toconfirm for these results, further studies on this topic will be warranted in the future.
Abstract
Although there are still controversies about whether hypertriglyceridemia is an independent risk factor for coronary arterydisease, recent analysis reported hypertriglyceridemia and central obesity are independent risk factors for coronary artery disease. However, the prognostic impact of hypertriglyceridemia and central obesity in acute myocardial infarction (AMI) patientsunderwent percutaneous coronary intervention (PCI) are still remained unclear. In this issue, Han et al. investigated the prognosticimpact of hypertriglyceridemia and/or central obesity on baseline in AMI patients treated with PCI. In this editorial, we havereviewed the role of hypertriglyceridemia and central obesity on the prognosis after PCI in AMI patients. Althoughhypertriglyceridemia and central obesity on baseline in this study had no role on the prognosis following PCI in AMI patients, toconfirm for these results, further studies on this topic will be warranted in the future.
참고문헌 (19)
- Gordon T, "Obesity and cardiovascular diseases: the Framingham study", Clin Endocrinol Metab, 5, pp.367~375 (1976)
- Kannel WB, "A general cardiovascular risk profile: the Framingham study", Am J Cardiol, 38, pp.46~51 (1976)
- Smith SC Jr, "AHA", ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute, 2006, pp.47, 2130~2139
- 한수경, "고중성지방혈증과 복부비만이 관상동맥 중재술을 시술받은 급성심근경색증 환자의 임상경과에 미치는 영향", 대한내과학회지, 86(2), pp.169~178 (2014), 대한내과학회[DOI]
- Cullen P, "Evidence that triglycerides are an independent coronary heart disease risk factor", Am J Cardiol, 86, pp.943~949 (2000)
- Grundy SM, "Two different views of the relationship of hypertriglyceridemia to coronary heart disease: implications for treatment", Arch Intern Med, 152, pp.28~34 (1992)
- Stampfer MJ, "A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction", JAMA, 276, pp.882~888 (1996)
- Austin MA, "Hypertriglyceridemia as a cardiovascular risk factor", Am J Cardiol, 81(2A), pp.7B~12B (1998)
- Assmann G, "The Munster Heart Study (PROCAM): results of follow-up at 8 years", Eur Heart J, 19(A), pp.A2~1 (1998)
- Bezafibrate Infarction Prevention (BIP) study, "Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease", Circulation, 102, pp.21~27 (2000)
- Rubins HB, "Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group", N Engl J Med, 341, pp.410~418 (1999)
- Hubert HB, "Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study", Circulation, 67, pp.968~977 (1983)
- Labounty TM, "Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients", Eur Heart J Cardiovasc Imaging, 14, pp.456~463 (2013)
- Lavie CJ, "Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss", J Am Coll Cardiol, 53, pp.1925~1932 (2009)
- Uretsky S, "Obesity paradox in patients with hypertension and coronary artery disease", Am J Med, 120, pp.863~870 (2007)
- Gruberg L, "The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox", J Am Coll Cardiol, 39, pp.578~584 (2002)
- Romero-Corral A, "Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies", Lancet, 368, pp.666~678 (2006)
- Kang WY, "Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction", J Cardiol, 55, pp.84~91 (2010)
- Dagenais GR, "Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease", Am Heart J, 149, pp.54~60 (2005)